Extracorporeal membrane oxygenation use, expenditure, and outcomes in taiwan from 2000 to 2010
about
Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approachECMO Used in a Refractory Ventricular Tachycardia and Ventricular Fibrillation Patient: A National Case-Control StudyH1N1 Influenza Patient Saved by Extracorporeal Membrane Oxygenation: First Report from Iran.Mobile ECMO - A divine technology or bridge to nowhere?Clinical risk factors of extracorporeal membrane oxygenation support in older adults.Early changes in coagulation profiles and lactate levels in patients with septic shock undergoing extracorporeal membrane oxygenation.
P2860
Extracorporeal membrane oxygenation use, expenditure, and outcomes in taiwan from 2000 to 2010
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@ast
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@en
type
label
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@ast
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@en
prefLabel
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@ast
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@en
P2093
P2860
P356
P1476
Extracorporeal membrane oxygen ...... es in taiwan from 2000 to 2010
@en
P2093
Chiao-Po Hsu
Chun-Che Shih
Chun-Yang Huang
Hsiu-Mei Wei
Shih-Hsien Sung
Tse-Min Lu
Wui-Chiang Lee
P2860
P304
P356
10.2188/JEA.JE20140027
P577
2015-03-21T00:00:00Z